Given the new ASCO guidelines on SNB in early stage breast cancer, how does the omission of SNB in patients aged 50-70 impact your adjuvant radiation recommendations?
For example, would you feel comfortable offering APBI to an otherwise low risk patient in her 50s who did not have a SNB?
Answer from: Radiation Oncologist at Academic Institution
If the patient is otherwise a good candidate for APBI (age > 50, pT1 tumor, ER+, HER2 negative, Recurrence score low and intending to take endocrine therapy) that was clinically node negative and ultrasound axilla negative, I feel completely comfortable treating with APBI post lumpectomy with neg...
Comments
Radiation Oncologist at Valley Medical Center Do you see value in treating with WBRT rather than...
Radiation Oncologist at Greater Baltimore Medical Center I do.
Do you see value in treating with WBRT rather than...
I do.